Moreover, although we observed an increase in MAP2 neurons in our in vitro assay from participants with recurrent symptoms, the morphology of these neurons was significantly impaired; they had fewer, shorter neurites and a less complex branching pattern—a finding that has previously been reported in stress models [62, 63], in older individuals with psychological distress [64], and in the context of late-life depression [65]. The gene discussed is MAP2; the disease is depressive symptom measurement.